Dr Khan received a B.Sc. degree in Chemistry from the University of Calcutta and a PhD degree in Medicinal Chemistry from University of Calcutta, followed by postdoctoral training at Karolinska Instiutet, Stockholm, Sweden and Medical University of South Carolina, USA, in the area of Neurodegenerative disorder and neurogenetics. Currently he is actively working in human healthcare industry with a broad understanding of diagnostics and regulatory practices.